SAN DIEGO, January 24, 2025--(BUSINESS WIRE)--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), announced today that, on January 28, 2025, the Company will implement a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback